Why the study?
Does androgen deprivation therapy increase the risk of cardiovascular disease in men with localised prostate cancer?
Does androgen deprivation therapy increase the risk of cardiovascular disease in men with localised prostate cancer?
Androgen deprivation therapy in men with localized prostate cancer is associated with an increased risk of incident heart failure, as well as arrhythmias and conduction disorders in those with preexisting cardiovascular disease.
Authors
No takes yet. Share an insight, caveat, or question.
ADT-associated CV risks in localized prostate cancer vary by baseline CVD status; leaves open causality and needs prospective validation.
Haque et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: